ACUVUE OASYS
Report
- Report Number
- 9617710-2018-05031
- Event Type
- Injury
- Date Received
- May 3, 2018
- Report Date
- April 11, 2018
- Manufacturer
- JOHNSON & JOHNSON VISION CARE, INC. ¿ IRELAND
- Product Code
- LPM
- PMA / PMN Number
- P040045
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- BR
- Reporter Occupation
- OTHER
Narratives
(B)(4). (B)(6).
ON (B)(6) 2018, A PATIENT (PT) FROM (B)(6) CALLED TO REPORT EXPERIENCING BLURRY VISION AND ITCHING IN THE LEFT EYE (OS) WHILE WEARING ACUVUE OASYS CONTACT LENSES (CLS). THE PT STATED THAT THE EVENT FIRST HAPPENED IN (B)(6) 2018. THE PT PRESENTED TO THE EYE CARE PROFESSIONAL (ECP) AND WAS DIAGNOSED WITH PALPEBRAL CONJUNCTIVITIS AND ¿BACTERIA IN THE EYE¿. TWO MEDICATIONS WERE PRESCRIBED, EYE DROPS AND A CREAM (NAMES, DOSAGE, FREQUENCY, AND DURATION WERE UNKNOWN), AND CL WEAR WAS SUSPENDED FOR 10 DAYS. THE PT STATED THAT THE CL APPEARED ¿DIRTY¿ AND THE CL HAD ¿THE FORMAT OF HER EYE¿ UPON REMOVAL. THE PT USED A MULTI-PURPOSE SOLUTION TO CLEAN THE CLS. THE PT STATED THAT AFTER THE TREATMENT WAS COMPLETED, ACUVUE OASYS CLS WERE USED WITHOUT FURTHER ISSUE. PT REFUSED TO PROVIDE ECP INFORMATION. ON (B)(6) 2018, THE PT WAS CONTACTED AND STATED THAT THE PT VISITED THE ECP ON (B)(6) 2018 AND WAS PRESCRIBED MAXIFLOX-D (CIPROFLOXACIN/DEXAMETASONE) 1 GTT EVERY 3 HRS FOR 10 DAYS. THE PT DID NOT HAVE THE INFORMATION FOR THE OTHER MEDICATION AVAILABLE. THE PT STATED THAT THE OS WAS BETTER AFTER 5-6 DAYS WITH USE OF THE MEDICATION. THE PT STATED THAT THE ECP FOLLOW-UP VISIT WAS AFTER THE 10 DAYS OF MEDICATION AND AT THAT TIME THE PT WAS CLEARED TO RETURN TO CL WEAR. THE PT SUCCESSFULLY RETURNED TO CL WEAR ON EITHER (B)(6) 2018 OR (B)(6) 2018. MULTIPLE ATTEMPTS WERE MADE TO OBTAIN MORE INFORMATION FROM THE PT, BUT WERE UNSUCCESSFUL. NO FURTHER INFORMATION WAS PROVIDED. THE SUSPECT PRODUCT IS NOT AVAILABLE FOR RETURN, AS IT WAS DISCARDED. A LOT HISTORY REVIEW WAS PERFORMED AND REVEALED THE FOLLOWING: THE BATCH RECORD DID NOT SHOW ANY ABNORMALITIES IN MONOMER AND SOLUTION TESTING. ALL PARAMETERS TESTED WERE WITHIN SPECIFICATION. ALL STERILIZATION REQUIREMENTS WERE SUCCESSFULLY COMPLETED. LOT L003488 WAS PRODUCED UNDER NORMAL CONDITIONS. IF ADDITIONAL INFORMATION IS RECEIVED, WILL REPORT WITHIN 30 DAYS OF RECEIPT. SERIOUS REPORTABLE EVENT TRENDS ARE REVIEWED QUARTERLY IN FRANCHISE MANAGEMENT REVIEW MEETINGS.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 326304 | ACUVUE OASYS | LENSES, SOFT CONTACT, EXTENDED WEAR | LPM | JOHNSON & JOHNSON VISION CARE, INC. ¿ IRELAND | NA | L003488 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | Other| R |